NO20030811D0 - Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer - Google Patents

Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer

Info

Publication number
NO20030811D0
NO20030811D0 NO20030811A NO20030811A NO20030811D0 NO 20030811 D0 NO20030811 D0 NO 20030811D0 NO 20030811 A NO20030811 A NO 20030811A NO 20030811 A NO20030811 A NO 20030811A NO 20030811 D0 NO20030811 D0 NO 20030811D0
Authority
NO
Norway
Prior art keywords
receptors
hta1
dopamine
treatment
diseases associated
Prior art date
Application number
NO20030811A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030811L (no
Inventor
Rudolf Gottschlich
Karl-August Ackermann
Helmut Pruecher
Christoph Seyfried
Gert Bartoszyk
Christoph Van Amsterdam
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030811L publication Critical patent/NO20030811L/no
Publication of NO20030811D0 publication Critical patent/NO20030811D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20030811A 2000-08-24 2003-02-21 Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer NO20030811D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10041574A DE10041574A1 (de) 2000-08-24 2000-08-24 Chromenonderivate
PCT/EP2001/008528 WO2002016354A1 (de) 2000-08-24 2001-07-24 Chromenonderivate und ihre verwendung zur behandlung von krankheiten im zusammenhang mit 5-hta1-rezeptoren und/oder dopamin-d2-rezeptoren

Publications (2)

Publication Number Publication Date
NO20030811L NO20030811L (no) 2003-02-21
NO20030811D0 true NO20030811D0 (no) 2003-02-21

Family

ID=7653636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030811A NO20030811D0 (no) 2000-08-24 2003-02-21 Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer

Country Status (16)

Country Link
US (1) US20040014768A1 (zh)
EP (1) EP1311503A1 (zh)
JP (1) JP2004506733A (zh)
KR (1) KR20030022390A (zh)
CN (1) CN1447807A (zh)
AU (1) AU2001289735A1 (zh)
BR (1) BR0113364A (zh)
CA (1) CA2420206A1 (zh)
CZ (1) CZ2003659A3 (zh)
DE (1) DE10041574A1 (zh)
MX (1) MXPA03001609A (zh)
NO (1) NO20030811D0 (zh)
PL (1) PL359222A1 (zh)
SK (1) SK2942003A3 (zh)
WO (1) WO2002016354A1 (zh)
ZA (1) ZA200302255B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
BRPI0509231A (pt) * 2004-03-26 2007-09-04 Lg Electronics Inc meio de gravação, método e aparelho para reproduzir fluxos de subtìtulo de texto
ATE450041T1 (de) 2004-03-26 2009-12-15 Lg Electronics Inc Aufzeichnungsmedium und verfahren und vorrichtung zum wiedergeben eines auf dem aufzeichnungsmedium aufgezeichneten textuntertitelstroms
RU2013131161A (ru) 2010-12-20 2015-01-27 Астразенека Аб Производное 2-карбоксамид-4-пиперазинил-бензофурана
CN104059046B (zh) * 2013-03-18 2017-02-08 江苏恩华药业股份有限公司 黄酮类衍生物及其应用
CN116332918A (zh) * 2023-03-17 2023-06-27 遵义医科大学珠海校区 香豆素-喹啉衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
DE4111861A1 (de) * 1991-04-11 1992-10-15 Schwabe Willmar Gmbh & Co Benzopyranone, verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
NO20030811L (no) 2003-02-21
ZA200302255B (en) 2004-08-16
US20040014768A1 (en) 2004-01-22
PL359222A1 (en) 2004-08-23
SK2942003A3 (en) 2003-09-11
MXPA03001609A (es) 2003-06-04
EP1311503A1 (de) 2003-05-21
KR20030022390A (ko) 2003-03-15
CN1447807A (zh) 2003-10-08
WO2002016354A1 (de) 2002-02-28
AU2001289735A1 (en) 2002-03-04
CZ2003659A3 (cs) 2003-06-18
CA2420206A1 (en) 2003-02-21
JP2004506733A (ja) 2004-03-04
DE10041574A1 (de) 2002-03-07
BR0113364A (pt) 2003-07-15

Similar Documents

Publication Publication Date Title
EE200500011A (et) Indasoolid, bensotiasoolid ja bensoisotiasoolid, nende valmistamine ning kasutamine
IS7079A (is) Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
NO20034430L (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1341786T3 (da) Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
NO20030811D0 (no) Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
IS6870A (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og notkun þeirra í meðferð
NO20043029L (no) Karboksamidinderivater og deres anvendelse ved behandling av vaskulaere sykdommer
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
EE200300570A (et) Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu
EE200300454A (et) Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
DE602004014138D1 (de) Benzothiazole derivate und ihre anwendung in der behandlung von adenosine a2a rezeptor vermittelte krankheiten
DE60304596D1 (de) In 3-position heterocyclisch substituierte pyridoindolonderivate, ihre herstellung und ihre therapeutische verwendung
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
IL163431A (en) 1 - phenyl - 2 - heteroaryl - substituted benzimidazole derivatives and the use thereof for producing drugs used in the treatment of immunological diseases
HUP0600114A2 (en) Benzofuran derivatives and their use in the treatment of microbal infections